ENvue Medical Inc Dossier
Qualitative Analysis
Business overview
ENvue Medical Inc. (NASDAQ: FEED), formerly known as NanoVibronix, Inc., is a commercial-stage medical technology company specializing in intelligent, non-invasive, and minimally invasive solutions for enteral care and therapeutic applications across clinical and home care settings. Headquartered in Tyler, Texas, with research and development operations in Tel-Aviv and Nesher, Israel, the company operates through two primary technology platforms. The first is the ENvue™ Navigation Platform, an FDA 510(k)-cleared electromagnetic navigation system that provides real-time bedside visualization to assist clinicians in placing feeding tubes safely and efficiently, thereby reducing the risk of preventable complications such as lung misplacement. The second platform consists of acoustic-based therapeutic technologies, including PainShield® and UroShield®, which utilize proprietary low-intensity surface acoustic wave (SAW) technology to treat pain, reduce bacterial colonization, and disrupt biofilms.
Research as of 24 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
An AI-powered training platform designed to help clinicians independently train on feeding tube placement using real-time guidance and feedback, addressing the training barrier to medical technology adoption.
Expected impact: Speeds up the adoption of the ENvue Navigation Platform, reduces implementation barriers for hospitals, and establishes a scalable recurring revenue stream.
An investigational robotic-assisted tool built within the ENvue electromagnetic navigation platform ecosystem that integrates AI navigation, real-time electromagnetic guidance, and robotic-assisted tube advancement.
Expected impact: Aims to automate bedside enteral access procedures under clinician supervision, enhancing safety and consistency while expanding the platform's clinical applications.
Strategic account expansion and deepening presence within major U.S. health systems and regional markets (such as Michigan and Texas) to transition feeding tube procedures from interventional radiology to bedside nursing care.
Expected impact: Drives higher utilization of the ENvue Navigation Platform and increases high-margin recurring sales of disposable enteral feeding tubes and accessories.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
NanoVibronix, Inc. acquired ENvue Medical Holdings Corp. in a stock-for-stock transaction to expand its market reach into the enteral feeding sector and create a combined platform for growth. Following the merger, the combined entity rebranded as ENvue Medical, Inc. in December 2025.
Financial impact: Resulted in ENvue stockholders holding approximately 85% of the consolidated entity and NanoVibronix stockholders holding 15%. The integration has introduced amortization of intangibles and transaction-related complexities.
Strategic Partnerships
High. Expands ENvue's presence in the non-acute enteral care market by distributing its over-the-counter reusable ENFit Syringes product line nationwide through digital, Amazon, and wholesale channels.
Terms: Not specified